甘精胰岛素与二甲双胍联合使用对不同体重指数2型糖尿病患者的疗效比较

下载PDF

导出

作者梁明欣秦桂花马哓琴

机构地区中国人民解放军第四七四医院内二科

出处《新疆医学》 2010年第12期64-66,共3页 Xinjiang Medical Journal

关键词 2型糖尿病甘精胰岛素联合使用二甲双胍体重指数胰岛素治疗疗效患者

参考文献5

1American diabetes association.Standards of Medical Care in Diabetes-2009.Diabetes Care,2009;32(sl):22-30.
2Adam WC and James RS.Obesity,Insulin Resistance,and Nocturnal Systolic Blood Pressure.Hypertension,2008;51(3):620-621.
3Kann PH,Wascher T,Zackova V,et al.Starting insulin therapy in type 2 diabetes:twice-daily biphasic insulin Aspart 30 plus Metforminformin versus once-daily insulin Glargineargine plus Glargineimepiride.Exp Clin Endocrinol Diabetes,2006;114(9):527-32.
4Melanie D,Fred S,Simon S,et al.Improvement of Glargineycemic Control in Subjects With Poorly Controlled Type 2 Diabetes.Comparison of two treatment algorithms using insulin Glargineargine.Diabetes Care,2005;28(6):1282-1288.
5程时武,陆菊明,潘长玉,汪保安,汪寅章,李一君,杨光,闫文华.重组甘精胰岛素注射液的人体药代动力学、药效学及生物等效性研究[J].中国糖尿病杂志,2010,18(5):387-391. 被引量：23

1《化学药物制剂人体生物利用度和生物等效性研究技术指导原则》课题研究组.化学药物制剂人体生物利用度和生物等效性研究技术指导原则.2005年3月,编号:[H] GCL2-1,P4-21.
2DeFronzo RA,Tobin JD,Andres R.Glucose clamp technique:a method for quantifying insulin secretion and resistance.Am J Physiol,1979,237:E214-E223.
3Ipp E,Sinai Y,Bar-Oz B,et al.Somatostatin impairs clearance of exogenous insulin in humans.Diabetes,1987,36:673-677.
4Heinemann L,Linkeschova R,Rave K,et al.Time-action profile of the long-acting insulin analog insulin glargine(HOE901)in comparison with those of NPH insulin and placebo.Diabetes Care,2000,23:644-649.
5Lepore M,Kurzhals R,Pampanelli S,et al.Pharmacokinetics and dynamics of s.c.injection of the long-acting insulin glargine(HOE901)in T1DM.Diabetes,1999,48:A97.
6Nicole L,Timothy HR,Rossa C,et al.Cross-reactivity of three recombinant insulin analogs with five commercial insulin immunoassays.Clinical Chemistry,2004,50:257-259.
7程时武,陆菊明,杨国庆,李一君,潘长玉,翟淮伟.高胰岛素-正常葡萄糖钳夹技术的建立[J].第四军医大学学报,2007,28(22):2082-2084. 被引量：7

新疆医学

2010年第12期

内容加载中请稍等...